Melissa Kartawinata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Melissa Kartawinata has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Lucy R. Wedderburn
University College London Great Ormond Street Institute of Child Health, London, UK
9 shared publications - Elizabeth C. Rosser
Centre for Adolescent Rheumatology at UCL, UCL Hospitals and Great Ormond Street Hospital (GOSH), London, UK
4 shared publications - Anne Maria Pesenacker
UCL Institute of Infection, Immunity and Transplantation
3 shared publications - Chris Wallace
MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
3 shared publications - Diana Shinko
Sydney Cytometry, The University of Sydney; Sydney, Australia
3 shared publications - Meryl H. Attrill
UCL Institute of Infection, Immunity and Transplantation
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 24 (1)
Challenges in linking interferon signatures to clinical trajectories in juvenile idiopathic arthritis
Background: Based on the recent finding that higher baseline expression of interferon (IFN)-driven gene signature in blood positively correlates with good response to methotrexate (MTX) in Juvenile Idiopathic Arthritis (JIA), this study tested the hypothesis that baseline IFN scores differ significantly between trajectory groups of response to MTX, defined by machine learning models enabling clinicians to predict not just the likelihood, but the specific longitudinal course of therapeutic response. Findings: Longitudinal clinical data from 699 children and young people (CYP) with active JIA initiating MTX and a nested sub-cohort of 102 CYP with previously available baseline blood transcriptomic data were analysed. Clinical disease courses were classified using multivariate group-based trajectory modelling, while baseline interferon activity was quantified using established 51-gene and 5-gene expression signatures derived from bulk RNASeq. There was no association between pre-treatment 51-gene and 5-gene IFN response scores and distinct clinical disease trajectories following methotrexate initiation by regression modelling. Post-hoc calculations indicated that the study was underpowered (44–58%) to detect medium effects, demonstrating that the increased clinical resolution provided by trajectory analysis significantly compromises statistical power in size-limited paediatric cohorts. Conclusions: Clinical trajectories accurately describe patient heterogeneity, but the IFN score does not represent a marker for a specific trajectory group?. Future stratification strategies require larger multi-centre cohorts to identify non-responders early and exploit the window of biological opportunity.
- 18 August 2026
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 24 (1)
Open AccessChallenges in linking interferon signatures to clinical trajectories in juvenile idiopathic arthritis
Background: Based on the recent finding that higher baseline expression of interferon (IFN)-driven gene signature in blood positively correlates with good response to methotrexate (MTX) in Juvenile Idiopathic Arthritis (JIA), this study tested the hypothesis that baseline IFN scores differ significantly between trajectory groups of response to MTX, defined by machine learning models enabling clinicians to predict not just the likelihood, but the specific longitudinal course of therapeutic response. Findings: Longitudinal clinical data from 699 children and young people (CYP) with active JIA initiating MTX and a nested sub-cohort of 102 CYP with previously available baseline blood transcriptomic data were analysed. Clinical disease courses were classified using multivariate group-based trajectory modelling, while baseline interferon activity was quantified using established 51-gene and 5-gene expression signatures derived from bulk RNASeq. There was no association between pre-treatment 51-gene and 5-gene IFN response scores and distinct clinical disease trajectories following methotrexate initiation by regression modelling. Post-hoc calculations indicated that the study was underpowered (44–58%) to detect medium effects, demonstrating that the increased clinical resolution provided by trajectory analysis significantly compromises statistical power in size-limited paediatric cohorts. Conclusions: Clinical trajectories accurately describe patient heterogeneity, but the IFN score does not represent a marker for a specific trajectory group?. Future stratification strategies require larger multi-centre cohorts to identify non-responders early and exploit the window of biological opportunity.
- Open Access
- 3 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 714
Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis
In Juvenile Idiopathic Arthritis (JIA), the most common childhood rheumatic disease, many patients also develop uveitis (JIA-uveitis), risking life-long vision loss. The mechanisms driving uveitis development in JIA remain understudied. Here, we demonstrate that peripheral blood CD19 + IgD - CD27 - double negative type 1 (DN1) B cells are elevated in JIA-uveitis compared to JIA patients without eye disease (JIA). The B cell receptor (BCR) repertoire was also more clonal and somatically hypermutated in JIA-uveitis and antigen-activated B cells infiltrated chronically inflamed JIA-uveitis eyes. Features of heightened B cell activation were recapitulated in experimental autoimmune uveoretinitis (EAU) and disrupting B and T cell interactions using monoclonal antibodies and transgenic mice suppresses uveitis. Together, these findings support a conceptual shift that uveitis is a primarily T cell driven disease and provide evidence for potential new therapeutic strategies that also consider B cells as drivers in disease pathology.
- 3 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 714
Open AccessAltered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis
In Juvenile Idiopathic Arthritis (JIA), the most common childhood rheumatic disease, many patients also develop uveitis (JIA-uveitis), risking life-long vision loss. The mechanisms driving uveitis development in JIA remain understudied. Here, we demonstrate that peripheral blood CD19 + IgD - CD27 - double negative type 1 (DN1) B cells are elevated in JIA-uveitis compared to JIA patients without eye disease (JIA). The B cell receptor (BCR) repertoire was also more clonal and somatically hypermutated in JIA-uveitis and antigen-activated B cells infiltrated chronically inflamed JIA-uveitis eyes. Features of heightened B cell activation were recapitulated in experimental autoimmune uveoretinitis (EAU) and disrupting B and T cell interactions using monoclonal antibodies and transgenic mice suppresses uveitis. Together, these findings support a conceptual shift that uveitis is a primarily T cell driven disease and provide evidence for potential new therapeutic strategies that also consider B cells as drivers in disease pathology.
- Open Access
- 2 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10193
Nuclear actin and DNA replication stress regulate telomere maintenance by telomerase
The recruitment of telomerase to telomeres is a tightly regulated process which is stimulated by replication stress and the DNA damage response regulatory kinase ATR, via an unknown mechanism. Here, we demonstrate that nuclear filamentous actin is important for the stable interaction of telomerase with telomeres in immortal human cells, resulting in productive telomere elongation by telomerase in an actin-dependent manner. This process is regulated by both ATR and mTOR kinases, and employs other regulators of actin structure and function, such as WASP, ARP2/3 and myosin. Nuclear filamentous actin serves as a site for telomerase recruitment, which is mediated by telomere tethering on actin fibers in response to replication stress, allowing telomerase to localize to telomeres containing stalled replication forks. Overall, these data demonstrate that, in human cells which express telomerase, telomeric replication stress triggers the recruitment of telomerase to telomeres via a nuclear actin network, enabling telomere length maintenance.
- 2 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10193
Open AccessNuclear actin and DNA replication stress regulate telomere maintenance by telomerase
The recruitment of telomerase to telomeres is a tightly regulated process which is stimulated by replication stress and the DNA damage response regulatory kinase ATR, via an unknown mechanism. Here, we demonstrate that nuclear filamentous actin is important for the stable interaction of telomerase with telomeres in immortal human cells, resulting in productive telomere elongation by telomerase in an actin-dependent manner. This process is regulated by both ATR and mTOR kinases, and employs other regulators of actin structure and function, such as WASP, ARP2/3 and myosin. Nuclear filamentous actin serves as a site for telomerase recruitment, which is mediated by telomere tethering on actin fibers in response to replication stress, allowing telomerase to localize to telomeres containing stalled replication forks. Overall, these data demonstrate that, in human cells which express telomerase, telomeric replication stress triggers the recruitment of telomerase to telomeres via a nuclear actin network, enabling telomere length maintenance.
- Open Access
- 9 August 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (10) , 1706-1720
Spatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signature
- 9 August 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (10) , 1706-1720
Open AccessSpatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signature
- Open Access
Spatial transcriptomic analysis of muscle biopsy from treatment-naive juvenile dermatomyositis patients reveals mitochondrial abnormalities despite disease-related interferon driven signature
Objectives: This study aimed to investigate the spatial transcriptomic landscape of muscle tissue from treatment-naïve juvenile dermatomyositis (JDM) patients in comparison to healthy paediatric muscle tissue. Methods: Muscle biopsies from three JDM patients and three age-matched controls were analysed using the Nanostring GeoMx® Digital Spatial Profiler. Regions of interest were selected based on muscle fibres without immune cells, immune cell infiltration and CD68+ macrophage enrichment. Differential gene expression, pathway analysis and pathways clustering analysis were conducted. Key findings were validated in 19 cases of JDM using immunohistochemistry and chemical stains, and a bulk RNAseq dataset of four cases of JDM. Results: JDM muscle tissues exhibited significant interferon pathway activation and mitochondrial dysfunction compared to controls. A 15-gene interferon signature was significantly elevated in JDM muscle and macrophage-enriched regions, correlating with clinical weakness. In contrast, mitochondrial dysregulation, characterized by downregulated respiratory chain pathways, was present regardless of interferon activity or muscle strength. The interferon-driven and mitochondrial signatures were replicated in an independent RNAseq dataset from JDM muscle; lack of association between interferon signature and mitochondrial dysregulation was validated in 19 cases by conventional staining methods. Clustering analysis revealed distinct transcriptomic profiles between JDM and control tissues, as well as between JDM patients with varying clinical phenotypes. Conclusions: This study highlights mitochondrial dysfunction as a consistent pathological feature in JDM muscle, which may be independent of interferon-driven inflammation. These findings highlight the potential for mitochondrial-targeted therapies in JDM management and emphasise the need for further studies to explore their therapeutic value. KEY MESSAGES: What is already known on this topic Juvenile dermatomyositis (JDM) involves interferon-driven inflammation and immune-mediated muscle damage. Mitochondrial abnormalities in blood immune cells persist despite treatment and contribute to disease pathology. What this study adds Mitochondrial dysfunction is present in both muscle fibres and tissue-infiltrating immune cells within JDM muscle. These abnormalities are detectable even in clinically less severe muscle weakness. Degree of mitochondrial abnormality at transcript and protein level may be independent of strength of IFN-driven signal. Mitochondrial dysregulation detected at transcriptional level correlates with abnormal transcription of muscle (sarcomere) and the subcellular peroxisome organelle. How this study might affect research, practice, or policy Targeting mitochondrial dysfunction could enhance treatment outcomes for JDM, especially in patients whose disease is refractory to current therapies. Insights from this study support the development of stratification tools to detect aspects of pathology which are not tightly correlated with IFN-driven pathology.
Open AccessSpatial transcriptomic analysis of muscle biopsy from treatment-naive juvenile dermatomyositis patients reveals mitochondrial abnormalities despite disease-related interferon driven signature
Objectives: This study aimed to investigate the spatial transcriptomic landscape of muscle tissue from treatment-naïve juvenile dermatomyositis (JDM) patients in comparison to healthy paediatric muscle tissue. Methods: Muscle biopsies from three JDM patients and three age-matched controls were analysed using the Nanostring GeoMx® Digital Spatial Profiler. Regions of interest were selected based on muscle fibres without immune cells, immune cell infiltration and CD68+ macrophage enrichment. Differential gene expression, pathway analysis and pathways clustering analysis were conducted. Key findings were validated in 19 cases of JDM using immunohistochemistry and chemical stains, and a bulk RNAseq dataset of four cases of JDM. Results: JDM muscle tissues exhibited significant interferon pathway activation and mitochondrial dysfunction compared to controls. A 15-gene interferon signature was significantly elevated in JDM muscle and macrophage-enriched regions, correlating with clinical weakness. In contrast, mitochondrial dysregulation, characterized by downregulated respiratory chain pathways, was present regardless of interferon activity or muscle strength. The interferon-driven and mitochondrial signatures were replicated in an independent RNAseq dataset from JDM muscle; lack of association between interferon signature and mitochondrial dysregulation was validated in 19 cases by conventional staining methods. Clustering analysis revealed distinct transcriptomic profiles between JDM and control tissues, as well as between JDM patients with varying clinical phenotypes. Conclusions: This study highlights mitochondrial dysfunction as a consistent pathological feature in JDM muscle, which may be independent of interferon-driven inflammation. These findings highlight the potential for mitochondrial-targeted therapies in JDM management and emphasise the need for further studies to explore their therapeutic value. KEY MESSAGES: What is already known on this topic Juvenile dermatomyositis (JDM) involves interferon-driven inflammation and immune-mediated muscle damage. Mitochondrial abnormalities in blood immune cells persist despite treatment and contribute to disease pathology. What this study adds Mitochondrial dysfunction is present in both muscle fibres and tissue-infiltrating immune cells within JDM muscle. These abnormalities are detectable even in clinically less severe muscle weakness. Degree of mitochondrial abnormality at transcript and protein level may be independent of strength of IFN-driven signal. Mitochondrial dysregulation detected at transcriptional level correlates with abnormal transcription of muscle (sarcomere) and the subcellular peroxisome organelle. How this study might affect research, practice, or policy Targeting mitochondrial dysfunction could enhance treatment outcomes for JDM, especially in patients whose disease is refractory to current therapies. Insights from this study support the development of stratification tools to detect aspects of pathology which are not tightly correlated with IFN-driven pathology.
- Open Access
- 20 May 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (8) , 1412-1424
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis
- 20 May 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (8) , 1412-1424
Open AccessIdentification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis
- Open Access
- 6 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (4)
Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes
Sex differences in immunity are well-documented, though mechanisms underpinning these differences remain ill-defined. Here, in a human-only ex vivo study, we demonstrate that postpubertal cisgender females have higher levels of CD19+CD27+IgD− class-switched memory B cells compared with age-matched cisgender males. This increase is only observed after puberty and before menopause, suggesting a strong influence for sex hormones. Accordingly, B cells express high levels of estrogen receptor 2 (ESR2), and class-switch–regulating genes are enriched for ESR2-binding sites. In a gender-diverse cohort, blockade of natal estrogen in transgender males (XX karyotype) reduced class-switched memory B cell frequency, while gender-affirming estradiol treatment in transgender females (XY karyotype) did not increase these levels. In postmenopausal cis-females, class-switched memory B cells were increased in those taking hormone replacement therapy (HRT) compared with those who were not. These data demonstrate that sex hormones and chromosomes work in tandem to impact immune responses, with estrogen only influencing the frequency of class-switched memory B cells in individuals with an XX chromosomal background.
- 6 March 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (4)
Open AccessEstrogen influences class-switched memory B cell frequency only in humans with two X chromosomes
Sex differences in immunity are well-documented, though mechanisms underpinning these differences remain ill-defined. Here, in a human-only ex vivo study, we demonstrate that postpubertal cisgender females have higher levels of CD19+CD27+IgD− class-switched memory B cells compared with age-matched cisgender males. This increase is only observed after puberty and before menopause, suggesting a strong influence for sex hormones. Accordingly, B cells express high levels of estrogen receptor 2 (ESR2), and class-switch–regulating genes are enriched for ESR2-binding sites. In a gender-diverse cohort, blockade of natal estrogen in transgender males (XX karyotype) reduced class-switched memory B cell frequency, while gender-affirming estradiol treatment in transgender females (XY karyotype) did not increase these levels. In postmenopausal cis-females, class-switched memory B cells were increased in those taking hormone replacement therapy (HRT) compared with those who were not. These data demonstrate that sex hormones and chromosomes work in tandem to impact immune responses, with estrogen only influencing the frequency of class-switched memory B cells in individuals with an XX chromosomal background.
- Open Access
- 5 August 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 218 (3) , 221-241
The immune landscape of the inflamed joint defined by spectral flow cytometry
Cellular phenotype and function are altered in different microenvironments. For targeted therapies it is important to understand site-specific cellular adaptations. Juvenile idiopathic arthritis (JIA) is characterized by autoimmune joint inflammation, with frequent inadequate treatment responses. To comprehensively assess the inflammatory immune landscape, we designed a 37-parameter spectral flow cytometry panel delineating mononuclear cells from JIA synovial fluid (SF) of autoimmune inflamed joints, compared to JIA and healthy control blood. Synovial monocytes and NK cells (CD56bright) lack Fc-receptor CD16, suggesting antibody-mediated targeting may be ineffective. B cells and DCs, both in small frequencies in SF, undergo maturation with high 4-1BB, CD71, CD39 expression, supporting T-cell activation. SF effector and regulatory T cells were highly active with newly described co-receptor combinations that may alter function, and suggestion of metabolic reprogramming via CD71, TNFR2, and PD-1. Most SF effector phenotypes, as well as an identified CD4-Foxp3+ T-cell population, were restricted to the inflamed joint, yet specific SF-predominant CD4+ Foxp3+ Treg subpopulations were increased in blood of active but not inactive JIA, suggesting possible recirculation and loss of immunoregulation at distal sites. This first comprehensive dataset of the site-specific inflammatory landscape at protein level will inform functional studies and the development of targeted therapeutics to restore immunoregulatory balance and achieve remission in JIA.
- 5 August 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 218 (3) , 221-241
Open AccessThe immune landscape of the inflamed joint defined by spectral flow cytometry
Cellular phenotype and function are altered in different microenvironments. For targeted therapies it is important to understand site-specific cellular adaptations. Juvenile idiopathic arthritis (JIA) is characterized by autoimmune joint inflammation, with frequent inadequate treatment responses. To comprehensively assess the inflammatory immune landscape, we designed a 37-parameter spectral flow cytometry panel delineating mononuclear cells from JIA synovial fluid (SF) of autoimmune inflamed joints, compared to JIA and healthy control blood. Synovial monocytes and NK cells (CD56bright) lack Fc-receptor CD16, suggesting antibody-mediated targeting may be ineffective. B cells and DCs, both in small frequencies in SF, undergo maturation with high 4-1BB, CD71, CD39 expression, supporting T-cell activation. SF effector and regulatory T cells were highly active with newly described co-receptor combinations that may alter function, and suggestion of metabolic reprogramming via CD71, TNFR2, and PD-1. Most SF effector phenotypes, as well as an identified CD4-Foxp3+ T-cell population, were restricted to the inflamed joint, yet specific SF-predominant CD4+ Foxp3+ Treg subpopulations were increased in blood of active but not inactive JIA, suggesting possible recirculation and loss of immunoregulation at distal sites. This first comprehensive dataset of the site-specific inflammatory landscape at protein level will inform functional studies and the development of targeted therapeutics to restore immunoregulatory balance and achieve remission in JIA.
- Open Access
Treg fitness as a biomarker for disease activity in Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA) is an autoimmune condition characterised by persistent flares of joint inflammation. However, no reliable biomarker exists to predict the erratic disease course. Normally, regulatory T cells (Tregs) maintain immune tolerance, with altered Tregs associated with autoimmunity. Treg signatures have shown promise in monitoring other autoimmune conditions, therefore a Treg gene and/or protein signature could offer novel biomarker potential for predicting disease activity in JIA. Machine learning on our nanoString Treg gene signature on peripheral blood (PB) Tregs generated a model to distinguish active JIA (active joint count, AJC≥1) Tregs from healthy controls (HC, AUC=0.9875). Biomarker scores from this model successfully differentiated inactive (AJC=0) from active JIA PB Tregs. Moreover, scores correlated with clinical activity scores (cJADAS), and discriminated subclinical disease (AJC=0, cJADAS≥0.5) from remission (AUC=0.8980, Sens=0.8571, Spec= 0.8571). To investigate altered Treg fitness in JIA by protein expression, we utilised spectral flow cytometry and unbiased analysis. Three Treg clusters were increased in active JIA PB, including CD226 high CD25 low effector-like Tregs and CD39-TNFR2-Helios high , while a 4-1BB low TIGIT low ID2 intermediate Treg cluster predominated in inactive JIA PB (AJC=0). The ratio of these Treg clusters correlated to cJADAS, and higher ratios could predict inactive individuals that flared by 6-month follow-up. Thus, we demonstrate altered Treg signatures and subsets as an important factor, and useful biomarker, for disease progression versus remission in JIA, revealing genes and proteins important in Treg fitness. Ultimately, PB Treg fitness measures could serve as routine biomarkers to guide disease and treatment management to sustain remission in JIA.
Open AccessTreg fitness as a biomarker for disease activity in Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA) is an autoimmune condition characterised by persistent flares of joint inflammation. However, no reliable biomarker exists to predict the erratic disease course. Normally, regulatory T cells (Tregs) maintain immune tolerance, with altered Tregs associated with autoimmunity. Treg signatures have shown promise in monitoring other autoimmune conditions, therefore a Treg gene and/or protein signature could offer novel biomarker potential for predicting disease activity in JIA. Machine learning on our nanoString Treg gene signature on peripheral blood (PB) Tregs generated a model to distinguish active JIA (active joint count, AJC≥1) Tregs from healthy controls (HC, AUC=0.9875). Biomarker scores from this model successfully differentiated inactive (AJC=0) from active JIA PB Tregs. Moreover, scores correlated with clinical activity scores (cJADAS), and discriminated subclinical disease (AJC=0, cJADAS≥0.5) from remission (AUC=0.8980, Sens=0.8571, Spec= 0.8571). To investigate altered Treg fitness in JIA by protein expression, we utilised spectral flow cytometry and unbiased analysis. Three Treg clusters were increased in active JIA PB, including CD226 high CD25 low effector-like Tregs and CD39-TNFR2-Helios high , while a 4-1BB low TIGIT low ID2 intermediate Treg cluster predominated in inactive JIA PB (AJC=0). The ratio of these Treg clusters correlated to cJADAS, and higher ratios could predict inactive individuals that flared by 6-month follow-up. Thus, we demonstrate altered Treg signatures and subsets as an important factor, and useful biomarker, for disease progression versus remission in JIA, revealing genes and proteins important in Treg fitness. Ultimately, PB Treg fitness measures could serve as routine biomarkers to guide disease and treatment management to sustain remission in JIA.
- Open Access
The immune landscape of the inflamed joint defined by spectral flow cytometry
Cellular phenotype and function are altered in different microenvironments. For targeted therapies it is important to understand site-specific cellular adaptations. Juvenile Idiopathic Arthritis (JIA) is characterised by joint inflammation, with frequent inadequate treatment responses. To comprehensively assess the inflammatory immune landscape, we designed a 37-parameter spectral flow cytometry panel delineating mononuclear cells from JIA synovial fluid (SF), compared to JIA and healthy control blood. Synovial monocytes and NK cells lack the Fc-receptor CD16, suggesting antibody-mediated targeting may be ineffective. B cells and DCs, both in small frequencies in SF, undergo maturation with high 4-1BB, CD71, CD39 expression, supporting T cell activation. SF effector and regulatory T cells were highly active with newly described co-receptor combinations that may alter function, and suggestion of metabolic reprogramming via CD71, TNFR2 and PD-1. Most SF effector phenotypes, as well as an identified CD4-Foxp3+ T cell population, were restricted to the inflamed joint, yet specific SF-predominant Treg (CD4+Foxp3+) subpopulations were increased in blood of active but not inactive JIA, suggesting possible recirculation and loss of immunoregulation at distal sites. This first comprehensive dataset of the site-specific inflammatory landscape at protein level will inform functional studies and the development of targeted therapeutics to restore immunoregulatory balance and achieve remission in JIA. Graphical
Open AccessThe immune landscape of the inflamed joint defined by spectral flow cytometry
Cellular phenotype and function are altered in different microenvironments. For targeted therapies it is important to understand site-specific cellular adaptations. Juvenile Idiopathic Arthritis (JIA) is characterised by joint inflammation, with frequent inadequate treatment responses. To comprehensively assess the inflammatory immune landscape, we designed a 37-parameter spectral flow cytometry panel delineating mononuclear cells from JIA synovial fluid (SF), compared to JIA and healthy control blood. Synovial monocytes and NK cells lack the Fc-receptor CD16, suggesting antibody-mediated targeting may be ineffective. B cells and DCs, both in small frequencies in SF, undergo maturation with high 4-1BB, CD71, CD39 expression, supporting T cell activation. SF effector and regulatory T cells were highly active with newly described co-receptor combinations that may alter function, and suggestion of metabolic reprogramming via CD71, TNFR2 and PD-1. Most SF effector phenotypes, as well as an identified CD4-Foxp3+ T cell population, were restricted to the inflamed joint, yet specific SF-predominant Treg (CD4+Foxp3+) subpopulations were increased in blood of active but not inactive JIA, suggesting possible recirculation and loss of immunoregulation at distal sites. This first comprehensive dataset of the site-specific inflammatory landscape at protein level will inform functional studies and the development of targeted therapeutics to restore immunoregulatory balance and achieve remission in JIA. Graphical